While BCMA expression has been described in pediatric B-ALL37 and in adults with B-ALL, Hodgkin Lymphoma (HL), and NHL,38 expression is highly variable and it does not appear to be a particularly promising therapeutic target in these contexts. Here, TNFRSF17 is linked to Hodgkins lymphoma.